CR10067A - Preservación y/o perfusión de órganos - Google Patents

Preservación y/o perfusión de órganos

Info

Publication number
CR10067A
CR10067A CR10067A CR10067A CR10067A CR 10067 A CR10067 A CR 10067A CR 10067 A CR10067 A CR 10067A CR 10067 A CR10067 A CR 10067A CR 10067 A CR10067 A CR 10067A
Authority
CR
Costa Rica
Prior art keywords
organ
perfusion
preservation
solution
bodies
Prior art date
Application number
CR10067A
Other languages
English (en)
Inventor
Lindon Young
Original Assignee
Philadelphia College Of Osteopathic Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/341,654 external-priority patent/US7326353B2/en
Application filed by Philadelphia College Of Osteopathic Medicine filed Critical Philadelphia College Of Osteopathic Medicine
Publication of CR10067A publication Critical patent/CR10067A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Solución de preservación, perfusión y/o reperfusión de un órgano, en especial el corazón, para transplantes. La solución contiene inhibidores de péptidos de proteína quinasa C E (PKC e). También se describen métodos para usar la solución de la invención, incluyendo métodos de preservación de un órgano para transplante, de protección de un órgano después de una isquemia, de mantenimiento de liberación de óxido nítrico y/o de liberación de superóxido en un órgano isquémico y de protección de un órgano contra los daños ocasionados cuando está aislado del sistema circulatorio.
CR10067A 2005-12-09 2008-06-12 Preservación y/o perfusión de órganos CR10067A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74864505P 2005-12-09 2005-12-09
US11/341,654 US7326353B2 (en) 2001-11-27 2006-01-30 Methods for reclaiming developing solvents

Publications (1)

Publication Number Publication Date
CR10067A true CR10067A (es) 2008-10-10

Family

ID=39324885

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10067A CR10067A (es) 2005-12-09 2008-06-12 Preservación y/o perfusión de órganos

Country Status (6)

Country Link
JP (1) JP2009521410A (es)
AU (1) AU2006349615B2 (es)
CA (1) CA2632777C (es)
CR (1) CR10067A (es)
DK (1) DK2056851T3 (es)
WO (1) WO2008051247A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060160062A1 (en) * 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013916A1 (en) * 1999-08-20 2001-03-01 Sagami Chemical Research Center Drugs inhibiting cell death
US20020168354A1 (en) * 2000-11-10 2002-11-14 Daria Mochly-Rosen psiepsilonRack peptide composition and method for protection against tissue damage due to ischemia
WO2002057413A2 (en) * 2001-01-18 2002-07-25 The Board Of Trustees Of The Leland Stanford Junior University Peptides for activation and inhibition of delta pkc
EP2228069A1 (en) * 2003-09-16 2010-09-15 Garvan Institute Of Medical Research Antagonists of protein kinase c-epsilon (pkcepsilon) and their use for the treatment of aberrant glucose metabolism associated therewith.
CA2549052A1 (en) * 2003-12-11 2005-06-30 The Board Of Trustees Of The Leland Stanford Junior University Isozyme-specific antagonists of protein kinase c
US7691861B2 (en) * 2004-01-19 2010-04-06 Novartis Ag Indolymaleimide derivatives
US7265092B2 (en) * 2004-09-30 2007-09-04 Kai Pharmaceuticals, Inc. Pharmaceutical formulation
US20060160062A1 (en) * 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs

Also Published As

Publication number Publication date
AU2006349615B2 (en) 2012-09-20
WO2008051247A1 (en) 2008-05-02
AU2006349615A1 (en) 2008-05-02
CA2632777A1 (en) 2008-05-02
JP2009521410A (ja) 2009-06-04
CA2632777C (en) 2019-08-20
DK2056851T3 (da) 2013-10-14

Similar Documents

Publication Publication Date Title
CR9250A (es) Solucion para la perfusion y/o la preservacion de organos
AR084378A1 (es) Combinaciones de compuestos activos
MX2021005012A (es) Compuestos, composiciones farmacéuticas y métodos de preparación de compuestos y de su uso como inhibidores de la cinasa atr.
CL2022003733A1 (es) Análogos de nucleósido de 1’-ciano y usos de los mismos
MX2010003291A (es) Supresion de tumores utilizando perfundido placentario humano y células destructoras naturales intermediarias derivadas de la placenta humana.
PE20090228A1 (es) Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c
EA200701660A1 (ru) Композиции и способы, предназначенные для хранения эритроцитов
CL2017000998A1 (es) Composición que comprende un agente de control biológico de la especie bacillus subtilis y un fungicida del grupo de inhibidores de la mitosis y la división celular, tal como fenamidona. (divisional solicitud 3272-2014)
ES2571104T3 (es) Estabilización del ARN y extracción del ARN presente en células intactas dentro de una muestra de sangre
CU23751B7 (es) Carbonilamino pirrolopirazoles, potentes inhibidores de quinasa
MX2009011002A (es) Composiciones de proteccion de isquemia/reperfusion y metodos de uso.
DOP2025000244A (es) Compuestos y métodos para el tratamiento de infecciones virales
CL2010001633A1 (es) Compuestos derivados de benzoxazina y benzotiazina, inhibidores de nos; composicion farmaceutica que los comprende; y su uso en el tratamiento de cefalea, dolor neuropatico, inflamatorio, visceral, neuroinfalamacion, hiperalgesia, alodinia, entre otras.
WO2008089103A8 (en) Targeting ncca-atp channel for organ protection following ischemic episode
TR201900937T4 (tr) Organların ve dokuların muhafaza edilmesine yönelik yöntem.
EA201890045A1 (ru) Комбинированные композиции для лечения нарушений, при которых требуется устранение или разрушение нежелательных клеточных пролифератов
PE20091164A1 (es) Inhibidores macrociclicos de la ns3 serina proteasa del virus de la hepatitis c
CL2013003307A1 (es) Agente que comprende ciazofamida o fenamidona; y su uso para tratar micosis en peces e invertebrados en todos sus estadios de desarrollo causada por hongos de los generos saprolegnia, achlya y aphanomyces (div.sol.n°1056-08).
CO2021015130A2 (es) Péptidos bnip3 para el tratamiento de la lesión por reperfusión
AR039819A1 (es) Solucion protectora para evitar danos isquemicos en organos
WO2004060321A3 (en) Cardioprotective delta opioid receptor agonists and methods of using same
CR10067A (es) Preservación y/o perfusión de órganos
BRPI0619561B8 (pt) métedo de conservação de um órgão para transplante, proteção de um órgão isquêmico, atenuação da disfunção de órgão após isquemia, ou proteção de um órgão do dano após isolação do sistema circulatório e solução compreendendo pelo menos um inibidor peptídico de proteína quinase
MX2016015635A (es) Metodos y composiciones para evitar la lesion por isquemia-reperfusion en organos.
WO2016127123A3 (en) Compounds and methods for preventing or treating sensory hair cell death

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)